(Q37247852)

19 August 2017

1 reference

title

Atypical antipsychotic-induced diabetes mellitus: an update on epidemiology and postulated mechanisms (English)

1 reference

19 August 2017

1 reference

S Buchholz

1

1 reference

19 August 2017

A F Morrow

series ordinal

2

1 reference

19 August 2017

P L Coleman

series ordinal

3

1 reference

19 August 2017

publication date

1 July 2008

1 reference

Internal Medicine Journal

19 August 2017

published in

1 reference

19 August 2017

volume

38

1 reference

19 August 2017

issue

7

1 reference

19 August 2017

page(s)

602-606

1 reference

Olanzapine-associated diabetes mellitus

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01712.X

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01712.X

Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01712.X

Incidence of diabetes in a general practice population: a database cohort study on the relationship with haloperidol, olanzapine, risperidone or quetiapine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01712.X

Antagonism of the serotonin (5-HT)-2 receptor and insulin sensitivity: implications for atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01712.X

Modulating effects of olanzapine on the development of diabetic ketoacidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01712.X

Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01712.X

Body weight gain after administration of antipsychotic drugs: correlation with leptin, insulin and reproductive hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01712.X

Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01712.X

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01712.X

Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01712.X

Effects of a high-fat diet and strain on hypothalamic gene expression in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01712.X

Fatal olanzapine-induced hyperglycemic ketoacidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01712.X

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01712.X

Tissue distribution of olanzapine in a postmortem case

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01712.X

Dominant-negative suppression of HNF-1alpha function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic beta-cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01712.X

Clozapine-associated diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01712.X

10.1111/J.1445-5994.2008.01712.X

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference